Germline IgM predicts T cell immunity to Pneumocystis

Kristin Noell, Guixiang Dai, Dora Pungan, Anna Ebacher, Janet E. McCombs, Samuel J. Landry, Jay K. KollsJCI 2022 · DOI

Abstract

Pneumocystis is a leading cause of opportunistic pneumonia in infants, particularly during the "window of vulnerability" between 3 and 6 months of age when maternal IgG levels decline. This study demonstrates that germline-encoded IgM antibodies, present even in newborns, serve as a critical targeting system for the adaptive immune response. By identifying fungal antigens recognized by these "natural" antibodies, researchers successfully predicted and validated specific proteins that trigger protective T cell responses. These findings highlight the role of B cells as essential antigen-presenting cells in early-life immunity against fungal pathogens.

Introduction

The peak incidence of Pneumocystis pneumonia in infants with primary immunodeficiencies (PIDs) occurs at an age when the immune system is dominated by IgM. While dendritic cells are the canonical antigen-presenting cells (APCs), previous research has shown that B cells are uniquely required for priming T cells against Pneumocystis. We hypothesized that germline-encoded IgM B cell receptors (BCRs) facilitate the capture and presentation of specific fungal antigens, thereby shaping the T cell repertoire before prior exposure.

Methods

To test this, we analyzed anti-Pneumocystis IgM in naive mice and human cord blood using ELISA and Western blotting. We performed immunoprecipitation (IP) using human cord blood IgM to isolate antigens from Pneumocystis murina lysates, identifying them via mass spectrometry. MHC class II binding predictions (NETMHCII) and Antigen Processing Likelihood (APL) algorithms were used to design peptides for T cell validation. Finally, we assessed protective immunity in Aicda−/− (IgM-only) and Rag2−/− (immunodeficient) mouse models through immunization and adoptive transfer experiments.

Results

Germline IgM Recognizes Conserved Fungal Antigens

We detected significant anti-Pneumocystis IgM reactivity in the sera of naive wild-type (WT) mice and human cord blood. Crucially, Aicda−/− mice, which cannot undergo class-switching to IgG, maintained robust IgM reactivity against fungal antigens. This confirms that the initial recognition of Pneumocystis is mediated by germline-encoded IgM rather than learned IgG responses.

Detection of anti-Pneumocystis IgM in naive WT and Aicda-/- mice. (A) Serum from naive WT mice shows reactivity to P. murina antigens. (B) Aicda-/- mice maintain this IgM reactivity, while Rag2-/- mice serve as a negative control.

Identification of Protective T Cell Antigens

IP of P. murina with human cord blood identified several shared antigens, including Meu10 and PNEG_01454. These proteins are conserved across murine and human Pneumocystis species. Peptides derived from these antigens elicited robust lung T cell responses in infected mice. Immunization with these recombinant proteins, followed by adoptive transfer of vaccine-elicited CD4+ T cells, significantly reduced fungal burden in challenged mice, demonstrating that these IgM-targeted antigens contain protective epitopes.

Discussion

Our data support a model where germline-encoded IgM BCRs are critical for antigen presentation and T cell priming during early Pneumocystis infection. B cells may be particularly effective APCs for this pathogen because high-affinity IgM receptors allow for the efficient capture and internalization of large fungal particles (asci) that might be less effectively processed by dendritic cells. The conservation of these antigens between mouse and human strains suggests an evolutionary adaptation to recognize stable fungal components. These findings could inform the development of neonatal vaccines and diagnostic tools to identify high-risk immunocompromised infants.

Summary updated

Abstract

Pneumocystis is the most common fungal pulmonary infection in children under the age of 5 years. In children with primary immunodeficiency, Pneumocystis often presents at 3-6 months of age, a time period that coincides with the nadir of maternal IgG and when IgM is the dominant Ig isotype. Because B cells are the dominant antigen-presenting cells for Pneumocystis, we hypothesized the presence of fungal-specific IgMs in humans and mice and that these IgM specificities would predict T cell antigens. We detected fungal-specific IgMs in human and mouse sera and utilized immunoprecipitation to determine whether any antigens were similar across donors. We then assessed T cell responses to these antigens and found anti-Pneumocystis IgM in WT mice, Aicda-/- mice, and in human cord blood. Immunoprecipitation of Pneumocystis murina with human cord blood identified shared antigens among these donors. Using class II MHC binding prediction, we designed peptides with these antigens and identified robust peptide-specific lung T cell responses after P. murina infection. After mice were immunized with 2 of the antigens, adoptive transfer of vaccine-elicited CD4+ T cells showed effector activity, suggesting that these antigens contain protective Pneumocystis epitopes. These data support the notion that germline-encoded IgM B cell receptors are critical in antigen presentation and T cell priming in early Pneumocystis infection.
BibTeX
@inproceedings{noell2022germline,
  author = {Kristin Noell and Guixiang Dai and Dora Pungan and Anna Ebacher and Janet E. McCombs and Samuel J. Landry and Jay K. Kolls},
  title = {{Germline IgM predicts T cell immunity to Pneumocystis}},
  booktitle = {JCI},
  year = {2022},
  doi = {10.1172/jci.insight.161450},
}
Figure